Your prediction
NeuroVive Pharmaceutical AB Stock
NeuroVive Pharmaceutical AB shows a slight decrease today, losing -€0.000 (-0.920%) compared to yesterday.
Pros and Cons of NeuroVive Pharmaceutical AB in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NeuroVive Pharmaceutical AB vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
NeuroVive Pharmaceutical AB | -0.920% | 71.429% | 38.462% | 27.059% | -12.195% | -79.029% | -89.615% |
BioInvent International AB | 1.210% | 12.332% | 40.730% | 6.823% | 52.744% | -52.691% | -2.718% |
India Globalization Capital | 18.030% | 26.728% | 10.000% | 87.075% | 109.924% | -50.091% | -49.900% |
Protara Therapeutics Inc. | 3.530% | 23.741% | 18.621% | 8.861% | 107.229% | -86.677% | - |